Dr. Sergey Suchkov, MD, Ph.D. Professor in Immunology & Medicine. Personal: Born 11 January 1957, Astrakhan, Russia.Honors: Secretary-General, United Cultural Convention, Cambridge, UK. Memberships: New York Academy of Sciences, USA; European Association for Predictive, Preventive and Personalized Medicine, Brussels; American Association for Research in Vision and Ophthalmology; International Society for Eye Research; EPMA Journal, Personalized Medicine Universe, Open J.Autoimmunity and American J.Cardiovascular Res. Editorial Boards; All-Union (from 1992 - Russian) Biochemical Society; All-Union (from 1992 - Russian) Immunological Society.
Medicine & Immunology
Anne Rios obtained her PhD in 2011. Her work represented a novel cell signaling mechanism that triggers the differentiation of a defined subset of cells within a stem pool (Nature, 2011). She then joined the laboratory of Professor Visvader focusing on Breast Cancer. A researcher at the Walter and Eliza Hall Institute (WEHI) in Melbourne, she was awarded the Neil Lawrence prize at the 2016 Centenary Institute Medical Innovation Awards for her project entitled ‘A journey into the unexpected: A 3D view of breast cancer’ which represented her post-doctoral work (Nature, 2014). She has developed a new 3D imaging technique that allows scientists to visualize entire breast tissues down to a single-cell level. She is the only researcher in Australia – and one of the few in the world – to do this. In 2017, she was appointed group leader at the Princess Máxima Center and Head the Princess Máxima Imaging Centre. She is currently investigating the cellular mechanisms underlying pediatric solid tumor progression using State-of-the-art imaging technologies.
Ming Pei completed his PhD from Beijing University, China and Postdoc training from Harvard-MIT Division of Health Sciences and Technology, USA. Currently he is a tenured Professor and Director of Stem Cell and Tissue Engineering Laboratory in the Department of Orthopaedics, West Virginia University, USA. He has over 100 publications that have been cited over 3100 times, and his publication H-index is 32 and has been serving as an editorial board member of reputed Journals.
Frank Leu is a co-founder and CEO of Novapeutics at Philadelphia, PA - a biopharma spun-out from the University of Pennsylvania, developing a first-in-class small molecule beta-cell restoration curative for the type 2 diabetes. Prior, Frank was at a specialty pharma, Verto Institute, developing antibody therapeutics for neuroendocrine cancer. Frank holds a doctorate degree in Pharmacology from the Weill Cornell Graduate School of Medical Sciences, and performed his posdoctoral work at a Howard Hughes Medical Institute lab at the Rockefeller University. Frank also founded BioPharMatrix, an advisory firm providing pragmatic vision and intelligence in the area of lifesciences; such as working with the 1776 (formerly Benjamins Desk) on shaping, developing and running of the Pennovation Center’s biopharma laboratories at the University of Pennsylvania.
Dr. Murugan Ramalingam is Professor at the Centre for Biomaterials, Cellular & Molecular Theranostics, VIT University, India. He hss also Adjunct Professor at the Tohoku University, Japan and Professeur des Universite at the Faculté de Chirurgie Dentaire, Université de Strasbourg, France. He has worked at the WPI Advanced Institute for Materials Research, Japan, as an Assistant Professor. He has also worked at the National Institute of Standards and Technology (NIST) and the National Institutes of Health (NIH), under the U.S. National Academies Associateship program. He received his Ph.D. in Biomaterials from the CSIR-Central Leather Research Institute, University of Madras. He has also undergone training in Ethical and Policy issues on Stem Cells from Harvard University, USA, and in Operations Management from the University of Illinois-Chicago. His current research interests are focused on the development of multiphase biomedical materials, through conventional to nanotechnology to biomimetic approaches, microfabrication and bioprinting, cell patterning, stem cell differentiation, tissue engineering and drug delivery. He is the author of ~300 publications, including 20 textbooks relevant to nanotechnology, biomaterials, stem cells, tissue engineering and regenerative medicine. His current h-index is 40 with ~9400 citations. He has delivered several keynote/invited talks and has chaired/organized several international conferences related to Biomaterials, Bioprinting, Nanobiotechnology, Stem Cells and Tissue Engineering. He also serves as a board member of several international scientific and research committees in various public and private bodies and grant reviewer of various international funding agencies. He serves on the editorial boards of multiple biomaterials and tissue engineering-related journals, including the Editor-in-Chief of the Journal of Biomaterials and Tissue Engineering and the Journal of Bionanoscience. He is a recipient of several prestigious fellowships and awards, including CSIR Fellowship (India), Singapore Millennium Fellowship (SMF) (Singapore), NRC National Academies Fellowship (USA), Nationale Professeur des Universités (France), Fellow of Royal Society of Biology (UK), Fellow of Institute of Nanotechnology (UK) and Fellow of Royal Society of Chemistry (UK).